Testosterone Cypionate Travel & Timezone-Shift Protocols
At a glance
- Half-life / about 8 days after intramuscular injection [1]
- Labeled dose / 50 to 400 mg every 2 to 4 weeks [1]
- Labeled route / deep gluteal intramuscular, never intravenous [1]
- US legal status / Schedule III controlled substance under the Controlled Substances Act [1]
- Hematocrit effect / intramuscular cypionate or enanthate raised mean hematocrit by 4.0% versus placebo [3]
- Label monitoring / periodic hemoglobin and hematocrit during long-term treatment [1]
- Competitive sport / prohibited at all times under WADA category S1 [4]
What does the label say about injection spacing and time zones?
Depo-Testosterone is labeled for replacement in hypogonadal men at 50 to 400 mg every two to four weeks, injected deep in the gluteal muscle [1]. The half-life of testosterone cypionate after intramuscular injection is approximately eight days [1].
The label gives a dose range and an interval measured in weeks. It does not give directions for moving an individual injection earlier or later, for a late or missed injection, or for crossing time zones [1].
How is the injection given?
Depo-Testosterone is for intramuscular use only and should not be given intravenously [1]. The label describes intramuscular use, not subcutaneous use [1]. It directs a visual check for particulate matter and discoloration before administration, whenever the solution and container permit [1].
What monitoring does the label describe?
In a network meta-analysis of 29 placebo-controlled trials in 3,393 men, intramuscular testosterone enanthate or cypionate raised mean hematocrit by 4.0% over placebo (95% CI 2.9 to 5.1) [3]. The Depo-Testosterone label calls for periodic hemoglobin and hematocrit checks during long-term treatment [1].
Venous thromboembolism, including deep vein thrombosis and pulmonary embolism, has been reported with testosterone products such as cypionate [1]. The label says to evaluate pain, edema, warmth and erythema in the lower extremity for DVT and acute shortness of breath for PE, and to discontinue testosterone cypionate and begin an appropriate workup if a venous thromboembolic event is suspected [1]. The label also says testosterone can increase blood pressure, that blood pressure should be monitored periodically, especially in men with hypertension, and that testosterone products are not recommended in patients with uncontrolled hypertension [1].
Legal and sport status
Testosterone is a Schedule III controlled substance under the Controlled Substances Act [1]. Under WADA's 2026 Prohibited List, exogenous testosterone is an S1 anabolic agent prohibited at all times, and athletes need a Therapeutic Use Exemption for permitted use [4].
Frequently asked questions
Can I move a testosterone cypionate injection for travel?
Do time zones change the injection schedule?
What does the label say about how the injection is given?
How much does injectable testosterone raise hematocrit?
What clot symptoms does the label list?
Is testosterone cypionate allowed in sport?
References
- U.S. National Library of Medicine, DailyMed. Depo-Testosterone (cypionate) intramuscular, Pharmacia & Upjohn/Pfizer (testosterone cypionate) prescribing information. Depo-Testosterone (cypionate) intramuscular, Pharmacia & Upjohn/Pfizer (testosterone cypionate) label
- Federal Register :: Request Access. Federal Register :: Request Access
- Nackeeran S, Kohn T, Gonzalez D, White J, Ory J, Ramasamy R. The Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Trials. J Urol. 2022;207(1):44-51. The Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Trials
- World Anti-Doping Agency. World Anti-Doping Agency